Fatigue is a common symptom in patients with inflammatory immune diseases. Patients may also experience fatigue as an adverse drug reaction of biologics used for an immune-mediated ...
Read more
12 APR
Inhalation of small capsule pieces through an inhaler is not harmful
Puncturing powder capsules for inhalation may cause small capsule pieces to break loose. Capsule pieces that are small enough to pass through the filter are sometimes inhaled when ...
Read more
04 APR
Guillain-Barré Syndrome after COVID-19 vaccination
Until October 12th 2022, the Netherlands Pharmacovigilance Centre Lareb received 72 reports of Guillain-Barré Syndrome (GBS) following COVID-19 vaccination. GBS is labeled as a ra ...
Read more
10 MAR
Propylthiouracil and ANCA vasculitis
The Netherlands Pharmacovigilance Centre Lareb received seven well-documented reports on propylthiouracil and anti-neutrophil cytoplasmic antibody (ANCA) positive vasculitis.
Prop ...
Read more
15 FEB
Call for abstracts for the ISoP Mid-Year Symposium 2023
This year the ISoP mid-year meeting will be hosted by the Netherlands Pharmacovigilance Centre Lareb on 1-2 June 2023 in Leiden, the Netherlands. This meeting will focus on connect ...
Read more
13 FEB
Higher probability of experiencing a side effect in women after COVID-19 vaccination
Females have a two-fold higher odds of experiencing an adverse event following immunization (AEFI) than males after a COVID-19 vaccination. This difference was greater after the fi ...
